President & CEO of Regeneron Pharmaceuticals, Inc. (REGN, Financial) Leonard S Schleifer sells 4,662 shares of REGN on 03/13/2013 at an average price of $175.01 a share.
Regeneron Pharmaceuticals, Inc. has a market cap of $16.75 billion; its shares were traded at around $171.84 with a P/E ratio of 25.4 and P/S ratio of 14.4.
For the complete insider trading history of REGN, click here.
Regeneron Pharmaceuticals, Inc. has a market cap of $16.75 billion; its shares were traded at around $171.84 with a P/E ratio of 25.4 and P/S ratio of 14.4.
CEO Recent Trades:
- President & CEO Leonard S Schleifer sold 4,662 shares of REGN stock on 03/13/2013 at the average price of 175.01. Leonard S Schleifer owns at least 151,360 shares after this. The price of the stock has decreased by 1.81% since.
- President & CEO Leonard S Schleifer sold 91,683 shares of REGN stock on 03/07/2013 at the average price of 175.33. Leonard S Schleifer owns at least 156,022 shares after this. The price of the stock has decreased by 1.99% since.
CFO Recent Trades:
- SVP Finance and Admin CFO Trea Murray A Goldberg sold 7,878 shares of REGN stock on 01/16/2013 at the average price of 172.16. Murray A Goldberg owns at least 64,902 shares after this. The price of the stock has decreased by 0.19% since.
- SVP Finance and Admin CFO Trea Murray A Goldberg sold 9,693 shares of REGN stock on 11/14/2012 at the average price of 147.59. Murray A Goldberg owns at least 89,537 shares after this. The price of the stock has increased by 16.43% since.
Directors and Officers Recent Trades:
- Director Eric M Shooter sold 10,000 shares of REGN stock on 02/26/2013 at the average price of 160. Eric M Shooter owns at least 5,000 shares after this. The price of the stock has increased by 7.4% since.
- Director Joseph L Goldstein sold 5,000 shares of REGN stock on 01/09/2013 at the average price of 185. The price of the stock has decreased by 7.11% since.
- Director Joseph L Goldstein sold 5,000 shares of REGN stock on 01/04/2013 at the average price of 180.83. The price of the stock has decreased by 4.97% since.
- SVP Clin Devel & Reg Affairs Peter Powchik sold 13,586 shares of REGN stock on 01/03/2013 at the average price of 182.11. Peter Powchik owns at least 16,522 shares after this. The price of the stock has decreased by 5.64% since.
- SVP Clin Devel & Reg Affairs Peter Powchik sold 16,979 shares of REGN stock on 12/20/2012 at the average price of 175.43. Peter Powchik owns at least 16,522 shares after this. The price of the stock has decreased by 2.05% since.
For the complete insider trading history of REGN, click here.
